As drug development costs and timelines increase, sponsors seek creative solutions to balance expenses without compromising quality or speed. While relocating resources to lower-cost countries can be effective, it faces limitations such as talent availability of talent or locality issues such as time-zone requirements or the need for local level expertise or presence. By relocating activities that do not need to be performed by country specific staff to cost optimized hubs, Sponsors can optimize their workforce and achieve cost, quality and efficiency gains if executed correctly.
This Webinar will explore the different types of activities that can be transitioned to low-cost hubs, how to avoid some of the pitfalls and risks associated with such a strategy and share some real-life examples these.
Three key take-aways
Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
.svg){kind=icon}
